{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T15:18:46Z","timestamp":1792682326524,"version":"4.5.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T00:00:00Z","timestamp":1272672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2010,5]]},"DOI":"10.1016\/j.antiviral.2010.01.002","type":"journal-article","created":{"date-parts":[[2010,1,19]],"date-time":"2010-01-19T10:47:38Z","timestamp":1263898058000},"page":"128-136","source":"Crossref","is-referenced-by-count":16,"title":["Antiviral drug profile of seasonal influenza viruses circulating in Portugal from 2004\/2005 to 2008\/2009 winter seasons"],"prefix":"10.1016","volume":"86","author":[{"given":"Vanessa","family":"Correia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena Rebelo","family":"de Andrade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu\u00eds A.","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angie","family":"Lackenby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Zambon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2010.01.002_bib1","series-title":"Robust Statistics: A Method of Coping with Outliers. AMC Technical Brief, No. 6","author":"AMC","year":"2001"},{"key":"10.1016\/j.antiviral.2010.01.002_bib2","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1177\/135965350701200S04.1","article-title":"Influenza virus susceptibility and resistance to oseltamivir","volume":"12","author":"Aoki","year":"2007","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.antiviral.2010.01.002_bib3","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.antiviral.2008.06.008","article-title":"Adamantane resistance in influenza A(H1) viruses increased in 2007 in South East Asia but decreased in Australia and some other countries","volume":"80","author":"Barr","year":"2008","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2010.01.002_bib4","volume":"vol. 1","author":"Bliss","year":"1967"},{"key":"10.1016\/j.antiviral.2010.01.002_bib5","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0166-3542(01)00219-4","article-title":"Susceptibility of recent Canadian influenza A and B virus isolates to different neuraminidase inhibitors","volume":"54","author":"Boivin","year":"2002","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2010.01.002_bib6","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1128\/JCM.28.3.495-503.1990","article-title":"Rapid and simple method for purification of nucleic acids","volume":"28","author":"Boom","year":"1990","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.antiviral.2010.01.002_bib7","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/S0140-6736(05)67338-2","article-title":"Incidence of adamantane resistance among influenza A(H3N2) viruses isolated worldwide from 1994 to 2005: a cause for concern","volume":"366","author":"Bright","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.antiviral.2010.01.002_bib8","doi-asserted-by":"crossref","first-page":"966","DOI":"10.3201\/eid1506.081357","article-title":"Oseltamivir- and amantadine-resistant influenza viruses A(H1N1)","volume":"15","author":"Cheng","year":"2009","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.antiviral.2010.01.002_bib9","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1177\/135965350701200S07.1","article-title":"Neuraminidase inhibitors and their role in avian and pandemic influenza","volume":"12","author":"Crusat","year":"2007","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.antiviral.2010.01.002_bib10","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1093\/jac\/dkl376","article-title":"Use of neuraminidase inhibitors to combat pandemic influenza","volume":"58","author":"Democratis","year":"2006","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.antiviral.2010.01.002_bib11","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1056\/NEJMoa054512","article-title":"Oseltamivir resistance during treatment of influenza A (H5N1) infection","volume":"353","author":"de Jong","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.antiviral.2010.01.002_bib12","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1086\/518936","article-title":"Surveillance of resistance to adamantanes among influenza A(H3N2) and A(H1N1) viruses isolated worldwide","volume":"196","author":"Deyde","year":"2007","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2010.01.002_bib13","unstructured":"ECDC, 2008. Oseltamivir resistance in seasonal influenza virus. ECDC Online [updated 9.10.08]. Available on http:\/\/ecdc.europa.eu\/en\/Health_Topics\/influenza\/news\/news_Influenza_081009.aspx#oseltamivir."},{"key":"10.1016\/j.antiviral.2010.01.002_bib14","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1128\/JCM.35.8.2076-2082.1997","article-title":"Multiple reverse transcription-PCR for surveillance of influenza A and B viruses in England and Wales in 1995 and 1996","volume":"35","author":"Ellis","year":"1997","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.antiviral.2010.01.002_bib15","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jcv.2007.10.019","article-title":"Detection of human influenza A(H1N1) and B strains with reduced sensitivity to neuraminidase inhibitors","volume":"41","author":"Escuret","year":"2008","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.antiviral.2010.01.002_bib16","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.antiviral.2005.07.004","article-title":"Sensitivity of influenza viruses to zanamivir and oseltamivir: a study performed on viruses circulating in France prior to the introduction of neuraminidase inhibitors in clinical practice","volume":"68","author":"Ferraris","year":"2005","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2010.01.002_bib17","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1002\/j.1460-2075.1985.tb04038.x","article-title":"The molecular basis of the specific anti-influenza action of amantadine","volume":"4","author":"Hay","year":"1985","journal-title":"EMBO J."},{"key":"10.1016\/j.antiviral.2010.01.002_bib18","series-title":"Advances in Molecular Biology and Targeted Treatment for AIDS","first-page":"343","article-title":"Resistance of influenza A viruses to amantadine and rimantadine","author":"Hay","year":"1991"},{"key":"10.1016\/j.antiviral.2010.01.002_bib19","unstructured":"Hayden, F.G., 2007. Influenza 1998\u20132007: antivirals update. Personal communication performed on behalf of WHO Epidemic and Pandemic Alert and Response Department for the Infectious Diseases Society of America. Available on www.idsociety.org\/."},{"key":"10.1016\/j.antiviral.2010.01.002_bib20","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.antiviral.2003.11.008","article-title":"Susceptibility of human influenza viruses from Australasia and South East Asia to the neuraminidase inhibitors zanamivir and oseltamivir","volume":"62","author":"Hurt","year":"2004","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2010.01.002_bib21","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.antiviral.2006.10.004","article-title":"Susceptibility of highly pathogenic A(H5N1) avian influenza viruses to the neuraminidase inhibitors and adamantanes","volume":"73","author":"Hurt","year":"2007","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2010.01.002_bib22","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S0140-6736(04)16934-1","article-title":"Resistant influenza A viruses in children treated with oseltamivir: descriptive study","volume":"364","author":"Kiso","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.antiviral.2010.01.002_bib23","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1097\/QCO.0b013e3283199797","article-title":"The potential impact of neuraminidase inhibitor resistant influenza","volume":"21","author":"Lackenby","year":"2008","journal-title":"Curr. Opin. Infect. Dis."},{"key":"10.1016\/j.antiviral.2010.01.002_bib24","series-title":"Poster presentation. The Third European Influenza Conference","article-title":"A European surveillance network for influenza antiviral resistance (VIRGIL)","author":"Lackenby","year":"2008"},{"key":"10.1016\/j.antiviral.2010.01.002_bib25","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1038\/4371108a","article-title":"Avian flu: isolation of drug-resistant H5N1 virus","volume":"437","author":"Le","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2010.01.002_bib26","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1128\/AAC.47.7.2264-2272.2003","article-title":"Neuraminidase sequence analysis and susceptibilities of influenza virus clinical isolates to zanamivir and oseltamivir","volume":"47","author":"McKimm-Breschkin","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2010.01.002_bib27","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1056\/NEJMra050740","article-title":"Neuraminidase inhibitors for influenza","volume":"353","author":"Moscona","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.antiviral.2010.01.002_bib28","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1056\/NEJMp0900648","article-title":"Global transmission of oseltamivir-resistant influenza","volume":"360","author":"Moscona","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.antiviral.2010.01.002_bib29","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0003-2697(79)90362-2","article-title":"Fluorometric assay of neuraminidase with a sodium (4-methylumbelliferyl-alpha-d-N-acetylneuraminate) substrate","volume":"94","author":"Potier","year":"1979","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.antiviral.2010.01.002_bib30","series-title":"Poster presentation. Options for the Control of Influenza VI","article-title":"Detection of oseltamivir resistance mutation N294S in humans with influenza A H5N1","author":"Saad","year":"2007"},{"key":"10.1016\/j.antiviral.2010.01.002_bib31","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1128\/JCM.38.4.1552-1558.2000","article-title":"Application of a fluorogenic PCR assay for typing and subtyping of influenza viruses in respiratory samples","volume":"38","author":"Schweiger","year":"2000","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.antiviral.2010.01.002_bib32","doi-asserted-by":"crossref","first-page":"3284","DOI":"10.1128\/AAC.00555-08","article-title":"Surveillance for neuraminidase inhibitor resistance among human influenza A and B viruses circulating worldwide from 2004 to 2008","volume":"52","author":"Sheu","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2010.01.002_bib33","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1038\/nature06528","article-title":"Structural basis for the function and inhibition of an influenza virus proton channel","volume":"451","author":"Stouffer","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2010.01.002_bib34","doi-asserted-by":"crossref","first-page":"3809","DOI":"10.1128\/AAC.46.12.3809-3816.2002","article-title":"Mechanism by which mutations at His274 alter sensitivity of influenza A virus N1 neuraminidase to oseltamivir carboxylate and zanamivir","volume":"46","author":"Wang","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"issue":"Suppl. 1","key":"10.1016\/j.antiviral.2010.01.002_bib35","doi-asserted-by":"crossref","first-page":"i5","DOI":"10.1093\/jac\/dki018","article-title":"Oseltamivir (Tamiflu\u00ae) and its potential for use in the event of an influenza pandemic","volume":"55","author":"Ward","year":"2005","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.antiviral.2010.01.002_bib36","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1001\/jama.295.8.jed60009","article-title":"Adamantane resistance in influenza A","volume":"295","author":"Weinstock","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.antiviral.2010.01.002_bib37","series-title":"WHO Manual on Animal Influenza Diagnosis and Surveillance. WHO Online","author":"WHO","year":"2002"},{"key":"10.1016\/j.antiviral.2010.01.002_bib38","unstructured":"WHO, 2009a. Influenza A virus resistance to oseltamivir and other antiviral medicines. WHO Online [updated 4.06.09]. Available on http:\/\/www.who.int\/csr\/disease\/influenza\/2008-9nhemisummaryreport\/en\/index.html."},{"key":"10.1016\/j.antiviral.2010.01.002_bib39","unstructured":"WHO, 2009b. Antiviral drugs and pandemic (H1N1) 2009. WHO Online [updated 6.10.09]. Available on http:\/\/www.who.int\/csr\/disease\/swineflu\/frequently_asked_questions\/swineflu_faq_antivirals\/en\/index.html."},{"key":"10.1016\/j.antiviral.2010.01.002_bib40","unstructured":"WHO, 2009c. Pandemic (H1N1) 2009\u2014update 71. WHO Online [updated 23.10.09]. Available on http:\/\/www.who.int\/csr\/disease\/swineflu\/laboratory23_10_2009\/en\/index.html."},{"key":"10.1016\/j.antiviral.2010.01.002_bib41","unstructured":"WHO, 2009d. Antiviral use and the risk of drug resistance. WHO Online [updated 25.09.09]. Available on http:\/\/www.who.int\/csr\/disease\/swineflu\/notes\/h1n1_antiviral_use_20090925\/en\/index.html."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354210000069?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354210000069?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,29]],"date-time":"2023-05-29T16:51:19Z","timestamp":1685379079000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354210000069"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,5]]}},"alternative-id":["S0166354210000069"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2010.01.002","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2010,5]]}}}